Weitere Artikel dieser Ausgabe durch Wischen aufrufen
To identify from the published literature the feasibility and the application of the individualized measures [Patient Generated Index (PGI), Schedule for the Evaluation of Individual Quality of Life (SEIQOL), and the short form of it (the direct weighting SEIQOL-DW)] in the context of cancer and to summarize the evidence on the psychometric properties of these measures.
Ovid Medline, PubMed, Embase, and CINAHL were searched up to April 2016. All studies were included if they reported information about the psychometric properties of the individualized measures and included patients diagnosed with any type of cancer at any age. Effect size (ES) was calculated to test for the responsiveness.
Fifty-four full articles were reviewed. Full-text assessment of these articles resulted in 27 eligible studies that were included in our analysis. The majority of the studies (81%) reported data on the SEIQOL-DW, and only 15% on the PGI. Fourteen areas of quality-of-life (QOL) concerns were identified by patients using the PGI with the top 4 being family (90%), health (85%), finance (85%), and work (80%). At the global level, the correlation between the individualized and standard measures ranged from 0.45 to 0.49 and, at the symptom level, from 0.26 to 0.51. The ES of the individualized measures was high (ranged from 0.98 to 1.0) in the studies that expected high positive change compared to standard QOL measures (ES = 0.1).
Individualized measures are feasible and acceptable among people with cancer and could easily be incorporated clinically and used in a research context. Individualized measures are sensitive to change and cover a wide range of patients QOL concerns in comparison with standard measures.
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten
Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:
Canadian Cancer Statistics. Special topic: Predictions of the future burden of cancer in Canada. 2015. Available from http://www.cancer.ca/en/cancer-information/cancer-101/canadian-cancer-statistics-publication/?region=qc.
Hoffman, B. (2005). survivors at work: A generation of progress. CA: A Cancer Journal for Clinicians, 55, 271–280.
Group, W. (1994). Development of the WHOQOL: Rationale and current status. International Journal of Mental Health, 23(3), 24–56. CrossRef
Peter M. Fayers, David Machin. (2007). Qulaity of life, second edition: The assessment, analysis and interpretation of patients reported outcomes. http://onlinelibrary.wiley.com/book/10.1002/9780470024522
Cella, D. F. (1995). Measuring quality of life in palliative care. Seminars in Oncology, 22(2 Suppl 3), 73–81. PubMed
Schipper, H., Clinch, J. J., & Olweny, C. L. M. (1996). Quality of life studies: Definitions and conceptual issues. In B. Spilker (Ed.), Quality of life and pharmaco-economics in clinical trials (pp. 11–23). Philadelphia: Lippincott-Raven Publishers.
Soni, M. K., & Cella, D. (2002). Quality of life and symptom measures in oncology: An overview. American Journal of Managed Care, 8(18 Suppl), S560–S573. PubMed
Patrick-Miller, L. J. (2003). Is there a role for the assessment of health-related quality of life in the clinical evaluation of novel cytostatic agents?: Commentary re: P. M. LoRusso, Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors . Clinical Cancer Research, 9, 2040– 2048, 2003. Clinical Cancer Research, 9(6), 1990–1994, 2003.
Osoba, D. (2004) Outcomes research applied. Paper presented at the ISOHRQL Symposium, Boston.
Institute of Medicine. (2001). Crossing the quality chasm: A new health system for the 21st century. http://www.nationalacademies.org/hmd/Reports/2001/Crossing-the-Quality-Chasm-A-New-Health-System-for-the-21st-Century.aspx.
Broadhead, J. K., Robinson, J. W., & Atkinson, M. J. (1998). A new quality-of-life measure for oncology: The SEIQoL. Journal of Psychosocial Oncology, 16(1), 21–35. CrossRef
World Health Organization. (2001). International classification of functioning, disability and health, 2nd revision edn. Geneva: WHO.
World Health Organization. (2008). International classification of functioning, disability and health: ICF. World Health Organization. http://www.who.int/classifications/icf/en/.
Stephen Polgar, Shane A. Thomas, S. A. (2013). Introduction to research in the health sciences (6th ed.). Elsevier Health Sciences.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, NJ: Lawrence Erlbaum Associates.
Willener, R., & Hantikainen, V. (2005). Individual quality of life following radical prostatectomy in men with prostate cancer. Urologic Nursing, 25(2), 88–90. (95–100). PubMed
Llewellyn, C., McGurk, M., & Weinman, J. (2007). The relationship between the Patient Generated Index (PGI) and measures of HR-QoL following diagnosis with head and neck cancer: Are illness and treatment perceptions determinants of judgment-based outcomes? British Journal of Health Psychology, 12(Pt 3), 421–437. CrossRefPubMed
Sundberg, K. K., et al. (2010). Long-term survivors of childhood cancer report quality of life and health status in parity with a comparison group. Pediatric Blood & Cancer, 55(2), 337–343. CrossRef
Lucchiari, C. et al. (2015). Cognitive strategies and quality of life of patients with high- grade glioma. Support Care Cancer. https://www.ncbi.nlm.nih.gov/pubmed/25761757.
- A review of the application, feasibility, and the psychometric properties of the individualized measures in cancer
Ala’ S. Aburub
Nancy E. Mayo
- Springer International Publishing
Neuer Inhalt/© Stellmach, Neuer Inhalt/© Maturus, Pluta Logo/© Pluta